Table 1 Characteristics, comorbidities, risk factors, procedures, postoperative complications and in-hospital outcomes in patients underwent TAVI in Spain in 2014/15, according to type 2 diabetes status
T2DM n = 715 | No T2DM n = 1426 | p value | |
|---|---|---|---|
Female sex, n (%) | 334 (46.71) | 751 (52.66) | 0.009 |
Age, mean (SD) | 79.52 (6.27) | 81.36 (6.71) | < 0.01 |
Age groups, n (%) | |||
40–79 years | 298 (41.68) | 401 (28.12) | < 0.01 |
80–84 years | 281 (39.3) | 538 (37.73) | |
≥ 85 years | 136 (19.02) | 487 (34.15) | |
Charlson comorbidity index, mean (SD)a | 1.22 (1) | 1.03 (0.96) | < 0.01 |
Congestive heart failure, n (%) | 204 (28.53) | 374 (26.23) | 0.257 |
Cerebrovascular disease, n (%) | 46 (6.43) | 73 (5.12) | 0.211 |
Dementia, n (%) | 5 (0.7) | 6 (0.42) | 0.395 |
Chronic pulmonary disease, n (%) | 208 (29.09) | 383 (26.86) | 0.276 |
Renal disease, n (%) | 195 (27.27) | 269 (18.86) | < 0.01 |
Ischemic heart disease, n (%) | 314 (43.92) | 478 (33.52) | < 0.01 |
Atrial fibrillation, n (%) | 221 (30.91) | 508 (35.62) | 0.030 |
Intermittent claudication, n (%) | 12 (1.68) | 28 (1.96) | 0.646 |
Endocarditis, n (%) | 1 (0.14) | 1 (0.07) | 0.618 |
Hypertension, n (%) | 432 (60.42) | 722 (50.63) | < 0.01 |
Lipid metabolism disorders, n (%) | 363 (50.77) | 509 (35.69) | < 0.01 |
Smoking, n (%) | 130 (18.18) | 213 (14.94) | 0.054 |
Obesity, n (%) | 123 (17.2) | 111 (7.78) | < 0.01 |
Catheterization, n (%) | 112 (15.66) | 228 (15.99) | 0.846 |
Computerized tomography of the torax, n (%) | 51 (7.13) | 104 (7.29) | 0.893 |
Magnetic resonance imaging, n (%) | 1 (0.14) | 4 (0.28) | 0.525 |
Pacemaker device implantation, n (%) | 100 (13.99) | 214 (15.01) | 0.529 |
Cardioversion, n (%) | 14 (1.96) | 35 (2.45) | 0.469 |
Balloon counterpulsation, n (%) | 3 (0.42) | 10 (0.7) | 0.429 |
Percutaneous coronary interventions | 30 (4.20) | 66 (4.63) | 0.648 |
Hemodialysis, n (%) | 20 (2.8) | 30 (2.1) | 0.316 |
Red blood cell transfusion, n (%) | 120 (16.78) | 215 (15.08) | 0.305 |
Infection, n (%) | 13 (1.82) | 35 (2.45) | 0.348 |
Mediastinitis, n (%) | 0 (0) | 1 (0.07) | 0.479 |
Functional disturbances following TAVI, n (%) | 6 (0.84) | 15 (1.05) | 0.638 |
Any post procedure complicationb | 19 (2.66) | 49 (3.44) | 0.332 |
Mortality, n (%) | 26 (3.64) | 73 (5.12) | 0.123 |
Length of stay, mean (SD) | 12.54 (11.43) | 12.83 (12.07) | 0.603 |
Cost, mean (SD) | 20,356 (8897) | 20,983 (9623) | 0.145 |